Application 207429
- Type
- ANDA
- Sponsor
- BEXIMCO PHARMS USA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | SOTALOL HYDROCHLORIDE | SOTALOL HYDROCHLORIDE | TABLET;ORAL | 80MG | No | No |
| 002 | SOTALOL HYDROCHLORIDE | SOTALOL HYDROCHLORIDE | TABLET;ORAL | 120MG | No | No |
| 003 | SOTALOL HYDROCHLORIDE | SOTALOL HYDROCHLORIDE | TABLET;ORAL | 160MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 10135-715 | Sotalol Hydrochloride | Sotalol Hydrochloride | Marlex Pharmaceuticals Inc | ANDA | Current |
| 10135-716 | Sotalol Hydrochloride | Sotalol Hydrochloride | Marlex Pharmaceuticals Inc | ANDA | Current |
| 10135-717 | Sotalol Hydrochloride | Sotalol Hydrochloride | Marlex Pharmaceuticals Inc | ANDA | Current |
| 76385-125 | Sotalol Hydrochloride | Sotalol Hydrochloride Tables AF | Bayshore Pharmaceuticals LLC | ANDA | Current |
| 76385-126 | Sotalol Hydrochloride | Sotalol Hydrochloride Tables AF | Bayshore Pharmaceuticals LLC | ANDA | Current |
| 76385-127 | Sotalol Hydrochloride | Sotalol Hydrochloride Tablets AF | Bayshore Pharmaceuticals LLC | ANDA | Current |